| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
Published online before print November 29, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article |
,
,,
*Centre for Microbial Diseases and Immunity Research and British Columbia Research Institute for Child and Family Health, University of British Columbia, Vancouver, Canada; and Inimex Pharmaceuticals Inc., Vancouver, British Columbia, Canada
 |
Abstract |
|---|
Host defense peptides (often called cationic antimicrobial peptides) have pleiotropic immunomodulatory functions. The human host defense peptide LL-37 is up-regulated at sites of infection and has little or no antimicrobial activity in tissue-culture media but under the same conditions, demonstrates immunomodulatory effects on epithelial cells, monocytes, and dendritic cells (DC). These effects include the induction of chemokine production in a mitogen-activated protein kinase-dependent manner in epithelial cell lines and monocytes and profound alterations of DC differentiation, resulting in the capacity to enhance a T helper cell type 1 response. Although the exact mechanisms of interaction between LL-37 and these cell types have not been elucidated, there is evidence for specific (i.e., receptor-mediated) and nonspecific interactions. The relative significance of the direct antimicrobial activities and immunomodulatory properties of LL-37 and other cationic host defense peptides in host defense remains unresolved. To demonstrate that antimicrobial activity was not necessarily required for the protection in vivo, model peptides were synthesized and tested for antimicrobial and immunomodulatory activities. A peptide with no antimicrobial activity was found to be protective in animal models of Staphylococcus aureus and Salmonella infection, implying that a host defense peptide can protect by exerting immunomodulatory properties.
Key Words: cathelicidin • host defense peptide • immunomodulator • innate immunity
This article has been cited by other articles:
|
|
 |
|
  G. Diamond, N. Beckloff, and L.K. Ryan Host Defense Peptides in the Oral Cavity and the Lung: Similarities and Differences J. Dent. Res., October 1, 2008; 87(10): 915 - 927. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. W. Lisanby, M. K. Swiecki, B. L. P. Dizon, K. J. Pflughoeft, T. M. Koehler, and J. F. Kearney Cathelicidin Administration Protects Mice from Bacillus anthracis Spore Challenge J. Immunol., October 1, 2008; 181(7): 4989 - 5000. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Anderson, P. S. Hiemstra, C. Ward, I. A. Forrest, D. Murphy, D. Proud, J. Lordan, P. A. Corris, and A. J. Fisher Antimicrobial peptides in lung transplant recipients with bronchiolitis obliterans syndrome Eur. Respir. J., September 1, 2008; 32(3): 670 - 677. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Overhage, A. Campisano, M. Bains, E. C. W. Torfs, B. H. A. Rehm, and R. E. W. Hancock Human Host Defense Peptide LL-37 Prevents Bacterial Biofilm Formation Infect. Immun., September 1, 2008; 76(9): 4176 - 4182. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Mendez-Samperio, E. Miranda, and A. Trejo Expression and Secretion of Cathelicidin LL-37 in Human Epithelial Cells after Infection by Mycobacterium bovis Bacillus Calmette-Guerin Clin. Vaccine Immunol., September 1, 2008; 15(9): 1450 - 1455. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. McLoughlin, J. C. Lee, D. L. Kasper, and A. O. Tzianabos IFN-{gamma} Regulated Chemokine Production Determines the Outcome of Staphylococcus aureus Infection J. Immunol., July 15, 2008; 181(2): 1323 - 1332. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Nagaoka, F. Niyonsaba, Y. Tsutsumi-Ishii, H. Tamura, and M. Hirata Evaluation of the effect of human {beta}-defensins on neutrophil apoptosis Int. Immunol., April 1, 2008; 20(4): 543 - 553. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Bachrach, H. Altman, P. E. Kolenbrander, N. I. Chalmers, M. Gabai-Gutner, A. Mor, M. Friedman, and D. Steinberg Resistance of Porphyromonas gingivalis ATCC 33277 to Direct Killing by Antimicrobial Peptides Is Protease Independent Antimicrob. Agents Chemother., February 1, 2008; 52(2): 638 - 642. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Christenson, L. Bjorkman, C. Tangemo, and J. Bylund Serum amyloid A inhibits apoptosis of human neutrophils via a P2X7-sensitive pathway independent of formyl peptide receptor-like 1 J. Leukoc. Biol., January 1, 2008; 83(1): 139 - 148. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Harder, R. Glaser, and J.-M. Schroder Review: Human antimicrobial proteins effectors of innate immunity Innate Immunity, December 1, 2007; 13(6): 317 - 338. [Abstract] [PDF]
|
|
|
|
|
|
J. Yu, N. Mookherjee, K. Wee, D. M. E. Bowdish, J. Pistolic, Y. Li, L. Rehaume, and R. E. W. Hancock Host Defense Peptide LL-37, in Synergy with Inflammatory Mediator IL-1beta, Augments Immune Responses by Multiple Pathways J. Immunol., December 1, 2007; 179(11): 7684 - 7691. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Bucki, A. G. Sostarecz, F. J. Byfield, P. B. Savage, and P. A. Janmey Resistance of the antibacterial agent ceragenin CSA-13 to inactivation by DNA or F-actin and its activity in cystic fibrosis sputum J. Antimicrob. Chemother., September 1, 2007; 60(3): 535 - 545. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Mookherjee, H. L. Wilson, S. Doria, Y. Popowych, R. Falsafi, J. Yu, Y. Li, S. Veatch, F. M. Roche, K. L. Brown, et al. Bovine and human cathelicidin cationic host defense peptides similarly suppress transcriptional responses to bacterial lipopolysaccharide J. Leukoc. Biol., December 1, 2006; 80(6): 1563 - 1574. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Dudal, C. Turriere, S. Bessoles, P. Fontes, F. Sanchez, J. Liautard, J.-P. Liautard, and V. Lafont Release of LL-37 by Activated Human V{gamma}9V{delta}2 T Cells: A Microbicidal Weapon against Brucella suis J. Immunol., October 15, 2006; 177(8): 5533 - 5539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Sigurdardottir, P. Andersson, M. Davoudi, M. Malmsten, A. Schmidtchen, and M. Bodelsson In Silico Identification and Biological Evaluation of Antimicrobial Peptides Based on Human Cathelicidin LL-37. Antimicrob. Agents Chemother., September 1, 2006; 50(9): 2983 - 2989. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G. Barlow, Y. Li, T. S. Wilkinson, D. M. E. Bowdish, Y. E. Lau, C. Cosseau, C. Haslett, A. J. Simpson, R. E. W. Hancock, and D. J. Davidson The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system J. Leukoc. Biol., September 1, 2006; 80(3): 509 - 520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Jenssen, P. Hamill, and R. E. W. Hancock Peptide Antimicrobial Agents Clin. Microbiol. Rev., July 1, 2006; 19(3): 491 - 511. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. E. Lau, D. M. E. Bowdish, C. Cosseau, R. E. W. Hancock, and D. J. Davidson Apoptosis of Airway Epithelial Cells: Human Serum Sensitive Induction by the Cathelicidin LL-37 Am. J. Respir. Cell Mol. Biol., April 1, 2006; 34(4): 399 - 409. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Nagaoka, H. Tamura, and M. Hirata An Antimicrobial Cathelicidin Peptide, Human CAP18/LL-37, Suppresses Neutrophil Apoptosis via the Activation of Formyl-Peptide Receptor-Like 1 and P2X7. J. Immunol., March 1, 2006; 176(5): 3044 - 3052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Mookherjee, K. L. Brown, D. M. E. Bowdish, S. Doria, R. Falsafi, K. Hokamp, F. M. Roche, R. Mu, G. H. Doho, J. Pistolic, et al. Modulation of the TLR-Mediated Inflammatory Response by the Endogenous Human Host Defense Peptide LL-37 J. Immunol., February 15, 2006; 176(4): 2455 - 2464. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
